In this episode, our hosts discuss the learnings from the recent Advisory Committee on Immunization Practices (ACIP) meeting and what it means for COVID vaccine scheduling going forward. They also break down the latest on new COVID boosters, mifepristone, and results from the latest quick poll on stress and chronic illness.

“I feel like we're not getting news specific to our community, so it feels really important for us to be breaking it down and talking about it. Because… a lot of science is talked about, and it's hard to read the data sometimes, so just having time together to break it down is helpful,” says Zoe Rothblatt, Associate Director of Community Outreach at GHLF.

Among the highlights in this episode:

0:08: Zoe summarizes the episode’s main topics

0:57: The FDA recently authorized an additional round of bivalent boosters for those 65 and older and those with weakened immune systems

2:14: Steven Newmark, Director of Policy at GHLF, discusses the Supreme Court preserving access to the medication mifepristone, allowing the drug to remain broadly available while litigation plays out in a lower court

3:15: Results from a recent GHLF COVID-19 Patient Support Program quick poll show that 75% of respondents had been moderately or very stressed due to their chronic illness in the past seven days

5:17: Steven and Zoe discuss waning immunity and hospitalization rates related to COVID-19, focusing on the higher rates in the 65+ age group

6:23: Our hosts break down the ACIP’s support for transitioning from the monovalent primary series to the bivalent shot for mRNA vaccines

8:02: Steven explains the ACIP's idea for a single annual COVID-19 vaccine dose, similar to the flu vaccine, to help with waning immunity

10:49: The importance of vaccine accessibility for both immunocompromised individuals and the general population to help stop the spread of COVID-19

12:39: What our hosts learned from this episode

Contact Our Hosts

Steven Newmark, Director of Policy at GHLF: snewmark@ghlf.org

Zoe Rothblatt, Associate Director, Community Outreach at GHLF: zrothblatt@ghlf.org

We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to thehealthadvocates@ghlf.org

Catch up on all our episodes on our website or on your favorite podcast channel.

In this episode, our hosts discuss the learnings from the recent Advisory Committee on Immunization Practices (ACIP) meeting and what it means for COVID vaccine scheduling going forward. They also break down the latest on new COVID boosters, mifepristone, and results from the latest quick poll on stress and chronic illness.
“I feel like we're not getting news specific to our community, so it feels really important for us to be breaking it down and talking about it. Because… a lot of science is talked about, and it's hard to read the data sometimes, so just having time together to break it down is helpful,” says Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Among the highlights in this episode:
0:08: Zoe summarizes the episode’s main topics
0:57: The FDA recently authorized an additional round of bivalent boosters for those 65 and older and those with weakened immune systems
2:14: Steven Newmark, Director of Policy at GHLF, discusses the Supreme Court preserving access to the medication mifepristone, allowing the drug to remain broadly available while litigation plays out in a lower court
3:15: Results from a recent GHLF COVID-19 Patient Support Program quick poll show that 75% of respondents had been moderately or very stressed due to their chronic illness in the past seven days
5:17: Steven and Zoe discuss waning immunity and hospitalization rates related to COVID-19, focusing on the higher rates in the 65+ age group
6:23: Our hosts break down the ACIP’s support for transitioning from the monovalent primary series to the bivalent shot for mRNA vaccines
8:02: Steven explains the ACIP's idea for a single annual COVID-19 vaccine dose, similar to the flu vaccine, to help with waning immunity
10:49: The importance of vaccine accessibility for both immunocompromised individuals and the general population to help stop the spread of COVID-19
12:39: What our hosts learned from this episode
Contact Our Hosts
Steven Newmark, Director of Policy at GHLF: <a href="mailto:snewmark@ghlf.org">snewmark@ghlf.org</a>
Zoe Rothblatt, Associate Director, Community Outreach at GHLF: <a href="mailto:zrothblatt@ghlf.org">zrothblatt@ghlf.org</a>
We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to <a href="mailto:thehealthadvocates@ghlf.org">thehealthadvocates@ghlf.org</a>
Catch up on all our episodes on our website or on your favorite podcast channel.

A podcast that breaks down major health news of the week to help you make sense of it all. Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.

A podcast that breaks down major health news of the week to help you make sense of it all. Our goal is to help you understand what&rsquo;s happening in the healthcare world to help you make informed decisions to live your best life.

The Health Advocates

A podcast that breaks down major health news of the week to help you make sense of it all. Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life. The podcast is part of the Global Healthy Living Foundation Podcast Network and hosted by Steven Newmark, Chief of Policy at GHLF, and Zoe Rothblatt, Director of Community Outreach at GHLF.

A podcast that breaks down major health news of the week to help you make sense of it all. Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life. The podcast is part of the Global Healthy Living Foundation Podcast Network and hosted by Steven Newmark, Chief of Policy at GHLF, and Zoe Rothblatt, Director of Community Outreach at GHLF.

Advertisement